NLRP3 inflammasome inhibitors as new therapeutic approach for Rett syndrome

NLRP3 inflammasome is an important machinery involved in immune responses. This project explores if its activation is a possible trigger to switch from pre-symptomatic conditions to symptomatic status. In addition, the project will also investigate if the use of inflammasome inhibitors, both chemical and natural compounds, can result in improvement.